Fig. 2From: Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic reviewForest plot of studies assessing pregnancy outcomes among patients on anti-TNFa compared with control groupsBack to article page